Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Clinical trial NCT06511908 · RECRUITING

Trial details

NCT number: NCT06511908
Sponsor: National Institute of Mental Health (NIMH)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Suicide Depressive Disorder, Treatment-Resistant Ketamine Molecular Mechanisms of Pharmacological Action Neurotransmitter Agents Excitatory Amino Acid Agents Physiological Effects of Drugs Depressive Disorder, Major Depressive Disorder Depression Mental Disorders Mood Disorders

Start date: 2024-11-06
Primary completion: 2027-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.